ReviewJournal of the American Heart Association2026
Role of a Heart Center for Women in the Prevention and Diagnosis of Atherosclerotic Cardiovascular Disease in Women.
Review in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There are sex differences in how atherosclerotic cardiovascular disease (ASCVD) manifests and progresses. Appropriate management requires not only recognition of sex-based clinical differences but in the social disparities may influence outcomes. The establishment of heart centers for women emerged as a response to the escalating deaths in women from cardiovascular disease from 1984 to 2000. Since then, studies have provided further insights into sex differences in ASCVD management. Preventing ASCVD remains crucial in reducing morbidity and death from cardiovascular events in women. Heart centers for women play a crucial role in managing ASCVD in women, with health care professionals at the forefront of this effort. This article summarizes the most current guideline-supported therapies and diagnostic tools essential for preventing and treating ASCVD in women. It also emphasizes the critical importance of acknowledging social determinants of health, fostering empathy and understanding among health care professionals, and asserts that increasing women's participation in cardiovascular trials is vital for advancing research and improving outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.